Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro
Language English Country Netherlands Media print
Document type Journal Article
PubMed
1699493
DOI
10.1016/0166-3542(90)90014-x
PII: 0166-3542(90)90014-X
Knihovny.cz E-resources
- MeSH
- Adenine analogs & derivatives chemical synthesis pharmacology MeSH
- Adenosine analogs & derivatives pharmacology MeSH
- Antiviral Agents * chemical synthesis pharmacology MeSH
- Cidofovir MeSH
- Cytosine analogs & derivatives chemical synthesis pharmacology MeSH
- DNA Viruses drug effects enzymology MeSH
- Guanine analogs & derivatives chemical synthesis pharmacology MeSH
- Reverse Transcriptase Inhibitors MeSH
- Nucleic Acid Synthesis Inhibitors MeSH
- Nucleotides chemical synthesis pharmacology MeSH
- Organophosphonates * MeSH
- Organophosphorus Compounds chemical synthesis pharmacology MeSH
- Purine-Nucleoside Phosphorylase metabolism MeSH
- Ribonucleotide Reductases metabolism MeSH
- In Vitro Techniques MeSH
- Tubercidin pharmacology MeSH
- Structure-Activity Relationship MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- 2-aminoadenosine MeSH Browser
- 3-deazaadenosine MeSH Browser
- 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine MeSH Browser
- 9-(3-hydroxy-2-phosphonomethoxypropyl)guanine MeSH Browser
- 9-(S)-(3-hydroxy-2-(phosphonomethoxy)propyl)adenine MeSH Browser
- adefovir MeSH Browser
- Adenine MeSH
- Adenosine MeSH
- Antiviral Agents * MeSH
- Cidofovir MeSH
- Cytosine MeSH
- Guanine MeSH
- Reverse Transcriptase Inhibitors MeSH
- Nucleic Acid Synthesis Inhibitors MeSH
- Nucleotides MeSH
- Organophosphonates * MeSH
- Organophosphorus Compounds MeSH
- Purine-Nucleoside Phosphorylase MeSH
- Ribonucleotide Reductases MeSH
- Tubercidin MeSH
Several N-(S)-(3-hydroxy-2-phosphonylmethoxypropyl) (HPMP) and N-(2-phosphonylmethoxyethyl) (PME) derivatives of purine bases (adenine, guanine, 2-aminoadenine, 3-deazaadenine) and cytosine inhibit the growth of various DNA viruses. PME-derivatives (PMEA, PMEG and PMEDAP) are also active against retroviruses. Both types of nucleotide analogues undergo phosphorylation by cellular nucleotide kinases to their mono- and diphosphates. The phosphorylation with crude extracts of L-1210 cells is potentiated by an ATP-regenerating system. HPMPA is phosphorylated faster than PMEA with or without the ATP-regenerating system. The HPMP and PME analogues inhibit several virus-encoded target enzymes and their cellular counterparts: (1) HSV-1 DNA polymerase is inhibited by the diphosphates of the PME series; the virus-encoded enzyme is more sensitive than HeLa DNA pol alpha and beta. PMEApp terminates the growing DNA chain; it specifically replaces dATP. HPMPApp also acts as an alternative substrate of dATP, but, in contrast with PMEApp, it permits limited chain growth. (2) Diphosphates of both series inhibit HSV-1 ribonucleotide reductase; the greatest inhibition of CDP reduction to dCDP is exhibited by HPMPApp and PMEApp. The enzyme isolated from a PMEA-resistant HSV-1 mutant proved less sensitive to PMEApp, hydroxyurea and HPMPApp. (3) Diphosphates of PME derivatives efficiently inhibit AMV(MAV) reverse transcriptase. (4) The purine HPMP and PME analogues and, even more so, their monophosphate derivatives inhibit purine nucleoside phosphorylase from L-1210 cells.
References provided by Crossref.org